Tag: FY25
Orchid Pharma registers 26% PAT in Q3 of FY25
Q3 results show strong momentum in YoY-9 month backed by expansion of its anti-microbial portfolio
Godavari Biorefineries achieves 12% YoY revenue growth in Q3 FY25
Revenue from operations rose to ₹447.3 crore, up from ₹398.0 crore in Q3 FY24, with an EBITDA of ₹39.7 crore and a Profit After Tax (PAT) of ₹5.8 crore.
Emcure Pharma registers 18% revenue growth, 30% PAT in Q3 of...
Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY